Sileshi, Tesemma
Telele, Nigus Fikrie
Burkley, Victoria
Makonnen, Eyasu
Aklillu, Eleni
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (CSA2016S-1618, CSA2016S-1618, CSA2016S-1618, CSA2016S-1618)
Fogarty International Center and the National Institute of Allergy and Infectious Disease of the National Institute of Health (43 TW009127, 43 TW009127, 43 TW009127)
Styrelsen för Internationellt Utvecklingssamarbete (CSA2016S-1618, CSA2016S-1618, CSA2016S-1618)
Center of Innovative Drug Development and Therapeutic Trial for Africa
Article History
Received: 2 April 2023
Accepted: 13 July 2023
First Online: 15 July 2023
Competing interests
: The authors declare no competing interests.